Previous studies have shown elevated IL-33 plasma levels in lung cancer [51], breast cancer [52,53], gastric cancer [54], and advanced pancreatic ductal adenocarcinoma [55]. Here, IL33 is linked to pancreatic ductal adenocarcinoma.